Interestingly, Borg et al reported a family with two missense mutations in MLH1 and a single truncating mutation in BRCA1. The double heterozygote for the missense MLH1 and truncating BRCA1 mutations developed BC but not colorectal or endometrial cancer. The gene discussed is MLH1; the disease is endometrial cancer.